RSS
27 Dec 2021

Kintor Pharma Provides Update on One of its Three Multi-Regional Phase 3 Trials of Proxalutamide for COVID-19

Author: admintech | Filed under: Press Release

SUZHOU, China, Dec. 27, 2021 /PRNewswire/ — Kintor Pharmaceutical Limited (“Kintor Pharma,” HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, today provided an update on its multi-regional study of proxalutamide for the…

This entry was posted on Monday, December 27th, 2021 at 7:54 am and is filed under Press Release. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

«

»